Therefore, the down-regulation of inflammatory cytokines due to NLRP3 deficiency or inhibition may result in the inhibition of COX2 signal activation, subsequently leading to the suppression of colorectal tumor development. This evidence concerns the gene NLRP3 and colorectal neoplasm.